A Study of Nasopharyngeal Carcinoma From Guangdong

A Prospective Cohort Study of Nasopharyngeal Carcinoma to Establish Prognostic Models, to Discover Toxicity Associated Predictors and to Validate Randomized Trials in Clinical Practice

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03003182

Enrollment

2000

Registered

2016-12-26

Start date

2017-05-10

Completion date

2021-05-31

Last updated

2017-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Cancer

Brief summary

This prospective cohort study aims to establish prognostic models, to discover toxicity associated predictors and to validate randomized trials in clinical practice.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* histological confirmed nasopharyngeal carcinoma; * scanned by magnetic resonance imaging from calvaria vertex to clavicles before treatment; * pretreatment Epstein-Barr virus deoxyribonucleic acid copy number is available; * irradiated with intensity-modulated radiotherapy;

Exclusion criteria

* finishing anticancer therapy in two or more hospitals; * pregnancy or lactation; * diagnosed with other sort of cancer before or during the treatment.

Design outcomes

Primary

Measure	Time frame
overall survival	3-years

Secondary

Measure	Time frame
Number of participants with treatment-related acute adverse events as assessed by CTCAE v4.0	30-days

Countries

China

Contacts

Primary ContactFang-Yun Xie, MD

xiefy@sysucc.org.cn+86-02087342618

Outcome results